Mitochondrial Base Excision Repair (BER) capacity drops off a cliff in aged brain tissue, with OGG1 and APE1 activity falling by 50-75%. While 8-oxoG is usually labeled a simple mutagenic lesion, its accumulation in the hippocampus suggests a more systemic regulatory failure. The data points to a transition from early compensatory OGG1 upregulation to a late-stage APE1 decline, creating a "toxic repair intermediate" state. In this scenario, unrepaired apurinic/apyrimidinic (AP) sites accumulate and act as physical sinks for PARP-1 and XRCC1, leading to localized metabolic exhaustion and transcriptional silencing.
The Mechanism: From Lesion to Lock
Normally, OGG1 excises 8-oxoG to leave an AP-site that APE1 rapidly processes. But in aging neurons where APE1 is the rate-limiting bottleneck, these sites persist. I suspect these persistent AP-sites have a higher affinity for PARP-1 than the original 8-oxoG lesion. This "PARP-1 trapping" on mitochondrial and nuclear DNA mimics the effect of synthetic PARP inhibitors, but it's driven endogenously by BER failure.
This sequestration causes two cascading problems:
- NAD+ Depletion: Persistent PARP-1 activation at these sites rapidly drains local NAD+ pools. This impairs mitochondrial respiration and sirtuin-mediated proteostasis.
- Transcriptional Arrest: In GC-rich promoter regions, 8-oxoG acts as an epigenetic toggle for immediate-early genes. When APE1 activity isn't sufficient, the OGG1-AP-site complex fails to recruit Polβ and XRCC1, effectively locking the gene in a non-functional state. This explains why APE1





























